Ornithyl amphotericin methyl ester treatment of experimental candidiasis in rats.
AUTOR(ES)
Galgiani, J N
RESUMO
After intravenous Candida albicans infection, rats received orinthyl amphotericin methyl ester, amphotericin B, or diluent intravenously. At doses of 0.1 and 0.5 mg/kg, the drugs were equally effective in preventing deaths. However, at doses of 2.0 mg/kg, mortality after treatment with amphotericin B was greater than that after placebo, whereas orinthyl amphotericin methyl ester was fully protective.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=179929Documentos Relacionados
- Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.
- Comparative neurotoxicities of amphotericin B and its mono-methyl ester derivative in rats.
- In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.
- Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.
- Immunity to experimental renal candidiasis in rats.
